
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
ERT has announced its involvement in MOBILISE-D, a clinical research project to enhance drug development and improve the clinical management of mobility loss.
For more on the clinical research project, click






